about
Biomarkers of Parkinson's disease: present and futureThe role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2Transcranial brain parenchymal sonography in neurodegenerative and psychiatric diseasesIllicit stimulant use is associated with abnormal substantia nigra morphology in humansUsefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3THyperechogenicity of the Substantia Nigra in Parkinson's Disease: Insights from Two Brothers with Markedly Different Disease Durations.Sonographic alteration of lenticular nucleus in focal task-specific dystonia of musicians.The diagnostic value of midbrain hyperechogenicity in ALS is limited for discriminating key ALS differential diagnoses.Transcranial sonography on Parkinson's disease and essential tremor.Is transcranial sonography useful to distinguish scans without evidence of dopaminergic deficit patients from Parkinson's disease?Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients.Structural abnormality of the substantia nigra in children with attention-deficit hyperactivity disorder.The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review.The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1.Recent imaging advances in neurology.Overview of quantitative susceptibility mapping.Does thoracic pump influence the cerebral venous return?Neuroimaging in pre-motor Parkinson's diseaseHyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.Detection of MPTP-induced substantia nigra hyperechogenicity in Rhesus monkeys by transcranial ultrasoundMilestones in magnetic resonance imaging and transcranial sonography of movement disorders.Dopamine transporter imaging using 99mTc-TRODAT-1 SPECT in Parkinson's diseaseNeuroimaging: current role in detecting pre-motor Parkinson's disease.The PRIPS study: screening battery for subjects at risk for Parkinson's disease.Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.MDS research criteria for prodromal Parkinson's disease.Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonographyThe role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy.Recognition and management of Parkinson's disease during the premotor (prodromal) phase.Submandibular gland needle biopsy for the diagnosis of Parkinson disease.Olfaction as a biomarker in Parkinson's disease.Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities.Development of Parkinson's disease biomarkers.Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD.Combined assessment of midbrain hyperechogenicity, hyposmia and motor asymmetry improves diagnostic accuracy in early Parkinson's disease.
P2860
Q24170134-2AA28CBB-A5CC-4E2D-A1E7-C3F51211F995Q27011665-9A728786-9B26-4D2B-8443-A1C7FC997C6AQ27026684-2FAAA309-9484-422A-BC04-9C5085160B8DQ28486143-0A79CFFA-5A67-4F2C-B886-70896E51EDA7Q28553194-EE87288A-F6DE-4196-80AF-EF0EE0FFD6A2Q28660352-F61DCB33-5313-459F-B35E-649FCB1DCC77Q30363964-527AEB44-9FE4-4B9D-9E81-4CAC4913DFC7Q30407001-2FE7F23A-D570-460F-AADF-0ADF688259F1Q30415153-9CABB2A5-6104-4DFF-B6DC-49CE30F63EDEQ30450612-25D530FB-7AFB-4894-B3BC-13E6C2E9EF5BQ30454441-786C596E-6CC6-4248-8932-6D0F765A9E41Q30454798-BAD0BF18-52F0-41FD-9621-0A9071E2D905Q30484377-3038E453-101E-47D8-9FAA-CBD033F88244Q30635471-78D65965-9089-418F-9A3C-EF71E9C187B2Q30829363-FCD344A8-BCA0-44D4-BF19-E489BF4FA8C3Q30916063-FFEC2CF2-4949-4168-8801-F061E5A9D132Q31115799-0D025BAA-9AC9-40F7-ADA0-CD49F1009FD9Q33452785-D077445C-A64E-4B72-B70F-7506364D2A0BQ33676222-FB884056-3F52-4807-87D7-5EA2072954E6Q33689486-778840EE-F990-4DA7-A3F8-733D53F0737DQ33785923-76F1FD3C-43D7-4474-8AD8-BBEF0A89D6DEQ33821309-74DDFF02-8B8B-45D6-8FBC-E9004DB15D3CQ33917085-429C540D-E024-4F71-93BD-E7A17BC58772Q34066195-480C902E-24A5-4773-BE7E-38F96849EECFQ34234625-97A082D6-28D1-4BBD-BBC1-95709FBE0C98Q34361343-81E305A6-BE3A-4C50-93E1-7C36A1B04BE8Q34372099-199E6AD9-ABE1-4DED-BF94-DED17D9744CAQ34463276-AE9BB8F0-9D4B-4D3F-94E3-7292AFA8E62AQ34498279-84ECD9BA-BB5D-4C2B-B632-A3664D2BCE8DQ34828339-256E2B9C-536E-49B9-B257-E3D6F8C78F03Q36332532-90F11173-D9D8-4AD9-B358-E9D3D12EE582Q37507963-01A19F9D-A9E2-41C3-8421-A8881BDED9A7Q37507968-5818533F-405E-4273-BA2C-C6C81AC6D69EQ37648832-A5325919-DF02-4E51-9824-FDCCCDF131AEQ37800097-B606FFC1-A39A-42E5-BB2F-BB274ABBDC7BQ37809870-BDB56D1F-A18C-489C-8AFF-A400429182C7Q37810992-5AC918A1-6BDB-4ADD-866A-84705C49CEAEQ37824440-6C543F41-8F85-4211-9B31-2D07329242A4Q38029716-A6726F37-E0E0-432A-A1EA-DD97B2C24FFDQ38045906-02022858-49F4-45D3-A716-DCA4B32D99F1
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Transcranial sonography in movement disorders.
@ast
Transcranial sonography in movement disorders.
@en
type
label
Transcranial sonography in movement disorders.
@ast
Transcranial sonography in movement disorders.
@en
prefLabel
Transcranial sonography in movement disorders.
@ast
Transcranial sonography in movement disorders.
@en
P1433
P1476
Transcranial sonography in movement disorders.
@en
P2093
Jana Godau
P304
P356
10.1016/S1474-4422(08)70239-4
P577
2008-11-01T00:00:00Z